Oslo, Norway (BUSINESS WIRE) Otivio AS, the company behind FlowOx™, an innovative technology for improving blood flow in patients with reduced peripheral circulation, today announced that the company will present its FlowOx™ system at Demo Day in the United States Congress.
Otivio will be one of four companies to present on Demo Day on February 9, 2016. The other companies are Hucon Global Ltd, Skannex AS and Smartfish AS. The event has been coordinated by Oslo Medtech, Innovation Norway, American Defence International and U.S. Representative Rick Larsen, Co-Chair of the Friends of Norway Caucas in the US Congress. The delegates present on Demo Day include high ranked politicians, health care officers, military officers, health care industry delegates and press.
“We are excited to be selected to present on Demo Day” said Iacob Mathiesen, CEO, Otivio. “The event gives us a unique opportunity connect with influential partners”. Otivio expects that FlowOx™ will be introduced in the US market in 12-18 months.
FlowOx™ is a novel system for treatment of peripheral arterial disease (PAD). Otivio has developed FlowOx™ for patients with cold feet, leg pain and chronic wounds which can be symptoms of PAD. Early long-term testing documents increased blood flow, pain reduction and wound healing.